247 related articles for article (PubMed ID: 20613523)
1. Clinical relevance of circulating donor-specific HLA antibodies.
Claas FH
Curr Opin Organ Transplant; 2010 Aug; 15(4):462-6. PubMed ID: 20613523
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Utility of the virtual crossmatch in solid organ transplantation.
Amico P; Hönger G; Steiger J; Schaub S
Curr Opin Organ Transplant; 2009 Dec; 14(6):656-61. PubMed ID: 19741534
[TBL] [Abstract][Full Text] [Related]
4. The role of the histocompatibility laboratory in desensitization for transplantation.
Leffell MS; Zachary AA
Curr Opin Organ Transplant; 2009 Aug; 14(4):398-402. PubMed ID: 19417655
[TBL] [Abstract][Full Text] [Related]
5. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
6. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
Sasaki N; Idica A; Hall B; Terasaki PI
Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
[TBL] [Abstract][Full Text] [Related]
7. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
8. Detection and clinical relevance of donor specific HLA antibodies: a matter of debate.
Roelen DL; Doxiadis II; Claas FH
Transpl Int; 2012 Jun; 25(6):604-10. PubMed ID: 22587521
[TBL] [Abstract][Full Text] [Related]
9. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
[TBL] [Abstract][Full Text] [Related]
10. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
Everly MJ
Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
[TBL] [Abstract][Full Text] [Related]
12. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
[TBL] [Abstract][Full Text] [Related]
13. Quantifying HLA-specific antibodies in patients undergoing desensitization.
Zachary A; Reinsmoen NL
Curr Opin Organ Transplant; 2011 Aug; 16(4):410-5. PubMed ID: 21666475
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
15. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
Billen EV; Christiaans MH; van den Berg-Loonen EM
Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
[TBL] [Abstract][Full Text] [Related]
17. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
Seveso M; Bosio E; Ancona E; Cozzi E
Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
[TBL] [Abstract][Full Text] [Related]
18. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibody.
Higgins R; Hathaway M; Lowe D; Lam F; Kashi H; Tan LC; Imray C; Fletcher S; Zehnder D; Chen K; Krishnan N; Hamer R; Briggs D
Transplantation; 2007 Oct; 84(7):876-84. PubMed ID: 17984841
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of antibodies to HLA antigens undetectable by the standard complement-dependent cytotoxicity test.
Slavcev A; Lácha J; Honsová E; Sajdlová H; Lodererová A; Vítko S; Valhová S; Stríz I; Ivasková E
Transpl Int; 2003 Dec; 16(12):872-8. PubMed ID: 12904845
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.
Gupta A; Sinnott P
Hum Immunol; 2009 Aug; 70(8):618-22. PubMed ID: 19374932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]